155 related articles for article (PubMed ID: 36209180)
1. Does It Matter What Screener We Use? A Comparison of Ultra-brief PHQ-4 and E-mwTool-3 Screeners for Anxiety and Depression Among People With and Without HIV.
Basaraba CN; Stockton MA; Sweetland A; Medina-Marino A; Lovero KL; Oquendo MA; Greene MC; Mocumbi AO; Gouveia L; Mello M; Dos Santos P; Suleman A; Mabunda D; Mandlate F; Xavier A; Fumo W; Massinga L; Khan S; Feliciano P; Kann B; Salem AF; Bezuidenhout C; Mootz JJ; Duarte CS; Cournos F; Wall MM; Wainberg ML
AIDS Behav; 2023 Apr; 27(4):1154-1161. PubMed ID: 36209180
[TBL] [Abstract][Full Text] [Related]
2. Examining brief and ultra-brief anxiety and depression screening methods in a real-world epilepsy clinic sample.
Munger Clary HM; Wan M; Conner K; Brenes GA; Kimball J; Kim E; Duncan P; Snively BM
Epilepsy Behav; 2021 May; 118():107943. PubMed ID: 33839449
[TBL] [Abstract][Full Text] [Related]
3. Validation of screening tools for depression and anxiety disorders in a primary care population with high HIV prevalence in Zimbabwe.
Chibanda D; Verhey R; Gibson LJ; Munetsi E; Machando D; Rusakaniko S; Munjoma R; Araya R; Weiss HA; Abas M
J Affect Disord; 2016 Jul; 198():50-5. PubMed ID: 27011359
[TBL] [Abstract][Full Text] [Related]
4. Validity of the Patient Health Questionnaire-9 to screen for depression in a high-HIV burden primary healthcare clinic in Johannesburg, South Africa.
Cholera R; Gaynes BN; Pence BW; Bassett J; Qangule N; Macphail C; Bernhardt S; Pettifor A; Miller WC
J Affect Disord; 2014; 167():160-6. PubMed ID: 24972364
[TBL] [Abstract][Full Text] [Related]
5. The Psychometric Properties of PHQ-4 Depression and Anxiety Screening Scale Among College Students.
Khubchandani J; Brey R; Kotecki J; Kleinfelder J; Anderson J
Arch Psychiatr Nurs; 2016 Aug; 30(4):457-62. PubMed ID: 27455918
[TBL] [Abstract][Full Text] [Related]
6. Validation of brief screening measures for depression and anxiety in young people with substance use disorders.
Bentley KH; Sakurai H; Lowman KL; Rines-Toth L; McKowen J; Pedrelli P; Evins AE; Yule AM
J Affect Disord; 2021 Mar; 282():1021-1029. PubMed ID: 33601674
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the psychological burden during the early disease trajectory in patients with intracranial tumors by the ultra-brief Patient Health Questionnaire for Depression and Anxiety (PHQ-4).
Renovanz M; Soebianto S; Tsakmaklis H; Keric N; Nadji-Ohl M; Beutel M; Ringel F; Wollschläger D; Hickmann AK
Support Care Cancer; 2019 Dec; 27(12):4469-4477. PubMed ID: 30904948
[TBL] [Abstract][Full Text] [Related]
8. Detecting Depression and Anxiety Among Adolescents in South Africa: Validity of the isiXhosa Patient Health Questionnaire-9 and Generalized Anxiety Disorder-7.
Marlow M; Skeen S; Grieve CM; Carvajal-Velez L; Åhs JW; Kohrt BA; Requejo J; Stewart J; Henry J; Goldstone D; Kara T; Tomlinson M
J Adolesc Health; 2023 Jan; 72(1S):S52-S60. PubMed ID: 36274021
[TBL] [Abstract][Full Text] [Related]
9. Validation of brief screening instruments for internalizing and externalizing disorders in Mozambican adolescents.
Lovero KL; Adam SE; Bila CE; Canda ED; Fernandes ME; Rodrigues TIB; Sander MCT; Mellins CA; Duarte CS; Dos Santos PF; Wainberg ML
BMC Psychiatry; 2022 Aug; 22(1):549. PubMed ID: 35962378
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Patient Health Questionnaire-4 (PHQ-4) to screen for depression and anxiety in the Greek general population.
Christodoulaki A; Baralou V; Konstantakopoulos G; Touloumi G
J Psychosom Res; 2022 Sep; 160():110970. PubMed ID: 35728338
[TBL] [Abstract][Full Text] [Related]
11. A computerized version of the Patient Health Questionnaire-4 as an ultra-brief screening tool to detect emotional disorders in primary care.
Cano-Vindel A; Muñoz-Navarro R; Medrano LA; Ruiz-Rodríguez P; González-Blanch C; Gómez-Castillo MD; Capafons A; Chacón F; Santolaya F;
J Affect Disord; 2018 Jul; 234():247-255. PubMed ID: 29549826
[TBL] [Abstract][Full Text] [Related]
12. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population.
Löwe B; Wahl I; Rose M; Spitzer C; Glaesmer H; Wingenfeld K; Schneider A; Brähler E
J Affect Disord; 2010 Apr; 122(1-2):86-95. PubMed ID: 19616305
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and correlates of depression and anxiety symptoms among out-of-school adolescent girls and young women in Tanzania: A cross-sectional study.
Kuringe E; Materu J; Nyato D; Majani E; Ngeni F; Shao A; Mjungu D; Mtenga B; Nnko S; Kipingili T; Mongi A; Nyanda P; Changalucha J; Wambura M
PLoS One; 2019; 14(8):e0221053. PubMed ID: 31419238
[TBL] [Abstract][Full Text] [Related]
14. Examining the psychometric properties of brief screening measures of depression and anxiety in chronic pain: The Patient Health Questionnaire 2-item and Generalized Anxiety Disorder 2-item.
Bisby MA; Karin E; Scott AJ; Dudeney J; Fisher A; Gandy M; Hathway T; Heriseanu AI; Staples L; Titov N; Dear BF
Pain Pract; 2022 Apr; 22(4):478-486. PubMed ID: 35258171
[TBL] [Abstract][Full Text] [Related]
15. An ultra-brief screening scale for anxiety and depression: the PHQ-4.
Kroenke K; Spitzer RL; Williams JB; Löwe B
Psychosomatics; 2009; 50(6):613-21. PubMed ID: 19996233
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity and specificity of the Distress Thermometer and a two-item depression screen (Patient Health Questionnaire-2) with a 'help' question for psychological distress and psychiatric morbidity in patients with advanced cancer.
Ryan DA; Gallagher P; Wright S; Cassidy EM
Psychooncology; 2012 Dec; 21(12):1275-84. PubMed ID: 21919118
[TBL] [Abstract][Full Text] [Related]
17. Validation of the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder-7 in Lithuanian individuals with anxiety and mood disorders.
Stanyte A; Fineberg NA; Podlipskyte A; Gecaite-Stonciene J; Macijauskiene J; Steibliene V; Burkauskas J
J Psychiatr Res; 2023 Aug; 164():221-228. PubMed ID: 37385000
[TBL] [Abstract][Full Text] [Related]
18. Validation of the combined Patient Health Questionnaire Anxiety and Depression Scale among people with HIV in Vietnam.
Nguyen MX; Zimmer C; Latkin CA; Lancaster KE; Dowdy DW; Hutton H; Chander G; Frangakis C; Gaynes BN; Sripaipan T; Tran HV; Go VF
Int J STD AIDS; 2023 Oct; 34(12):832-840. PubMed ID: 37287254
[TBL] [Abstract][Full Text] [Related]
19. Examining the optimal cutoff values of HADS, PHQ-9 and GAD-7 as screening instruments for depression and anxiety in irritable bowel syndrome.
Snijkers JTW; van den Oever W; Weerts ZZRM; Vork L; Mujagic Z; Leue C; Hesselink MAM; Kruimel JW; Muris JWM; Bogie RMM; Masclee AAM; Jonkers DMAE; Keszthelyi D
Neurogastroenterol Motil; 2021 Dec; 33(12):e14161. PubMed ID: 33938601
[TBL] [Abstract][Full Text] [Related]
20. Optimizing screening for depression, anxiety disorders, and post-traumatic stress disorder in inpatient addiction treatment: A preliminary investigation.
Levitt EE; Syan SK; Sousa S; Costello MJ; Rush B; Samokhvalov AV; McCabe RE; Kelly J; MacKillop J
Addict Behav; 2021 Jan; 112():106649. PubMed ID: 32979691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
